Reproductive Medicine Network Biologic Specimen Repository

Completed

• Conditions: Infertility

• Registration Number: NCT01180387
• Lead Sponsor: Yale University

Brief Summary

The Reproductive Medicine Network (RMN) is a nationwide cooperative network of 7 clinical sites and a data coordination center, and is sponsored in 5 year increments by The Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD). The RMN is charged with designing, implementing and publishing high quality clinical research in reproductive medicine. It has been in existence for over 15 years and has performed several seminal clinical trials that have fundamentally changed clinical practice in this field. In addition, many worthy ancillary protocols have been generated and published.

It is this latter fact, as well as the continued interest by investigators both inside and outside the RMN for access to DNA or serum samples from the previously performed trials, that has motivated the present investigators to proactively begin a biologic samples repository from the ongoing and pending RMN clinical trials. Ideally, this repository would allow investigators to seamlessly access trial samples for many years into the future, and thus greatly amplify the use of resources and the impact of the RMN.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2010-08-05
• Study First Submitted QC: 2010-08-10
• Study First Posted: 2010-08-12
• Study Start: 2010-09
• Primary Completion: 2014-11
• Study Completion: 2015-01
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-02
• Last Update Posted: 2015-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1640

Inclusion Criteria

• Any subject of an RMN clinical trial and consents to participate in the repository is eligible for inclusion.

Read More

Exclusion Criteria

• N/A

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of subject who accepted participation	4.2 years

Trial Locations

Locations (15)

University of Alabama Birmingham; 🇺🇸 Birmingham, Alabama, United States

University of Texas Health Science Center at San Antonio; 🇺🇸 San Antonio, Texas, United States

Hackensack University; 🇺🇸 Hackensack, New Jersey, United States

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States

University of California, San Francisco; 🇺🇸 San Francisco, California, United States

Stanford University Medical Center; 🇺🇸 Stanford, California, United States

University of Colorado; 🇺🇸 Aurora, Colorado, United States

University of Connecticut; 🇺🇸 Storrs, Connecticut, United States

University of Oklahoma Health Sciences Center; 🇺🇸 Oklahoma City, Oklahoma, United States

Virginia Commonwealth University, School of Medicine; 🇺🇸 Richmond, Virginia, United States

Pennsylvania State University College of Medicine; 🇺🇸 Hershey, Pennsylvania, United States

University of Vermont; 🇺🇸 Burlington, Vermont, United States

University of Michigan; 🇺🇸 Ann Arbor, Michigan, United States

Wayne State University; 🇺🇸 Detroit, Michigan, United States

Carolinas Medical Center; 🇺🇸 Charlotte, North Carolina, United States